Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
Andrew Fleming, Vanessa Raabe
Topics & Concepts
Convalescent plasmaCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Current (fluid)2019-20 coronavirus outbreakMedicineAntibodyVirologyInternal medicineImmunologyPhysicsDiseaseOutbreakThermodynamicsInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCancer Immunotherapy and Biomarkers